UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 68

Sortiert nach

Evaluating the relationship between clinical and demographic characteristics of insulin-using people with diabetes and their health outcomes: a cluster analysis application

BMC health services research, 2021-07, Vol.21 (1), p.1-669, Article 669

2021

Volltextzugriff (PDF)

The Health Effects of Restricting Prescription Medication Use Because of Cost

Medical care, 2004-07, Vol.42 (7), p.626-634

2004

Volltextzugriff (PDF)

Insulin Dosing and Outcomes Among Commercially Insured Patients With Type 2 Diabetes in the United States

Clinical therapeutics, 2015-10, Vol.37 (10), p.2297-2308.e1

2015

Volltextzugriff (PDF)

Adherence and Persistence to Insulin Therapy in People with Diabetes: Impact of Connected Insulin Pen Delivery Ecosystem

Journal of diabetes science and technology, 2022-07, Vol.16 (4), p.995-1002

2022

Volltextzugriff (PDF)

Treatment patterns, costs, and mortality among Medicare beneficiaries with CIED infection

Pacing and clinical electrophysiology, 2018-05, Vol.41 (5), p.495-503

2018

Volltextzugriff (PDF)

Predictors of insulin pump initiation among people with type 2 diabetes from a US claims database using machine learning

Current medical research and opinion, 2023-06, Vol.39 (6), p.843-853

2023

Volltextzugriff (PDF)

50-LB: Using Cluster Analysis to Identify Attitudes towards Diabetes-Related Technology

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Incidence, Treatment Intensity, and Incremental Annual Expenditures for Patients Experiencing a Cardiac Implantable Electronic Device Infection: Evidence From a Large US Payer Database 1-Year Post Implantation

Circulation. Arrhythmia and electrophysiology, 2016-08, Vol.9 (8), p.e003929-e003929

2016

Volltextzugriff (PDF)

Trends in U.S. Insulin Use and Glucose Monitoring for People with Diabetes: 2009-2018

Journal of diabetes science and technology, 2022-11, Vol.16 (6), p.1428-1435

2022

Volltextzugriff (PDF)

75-LB: Use of Continuous Glucose Monitoring (CGM) and Its Association with Economic Outcomes in the Real-World Setting

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

1033-P: Trends in U.S. Insulin Use for People with Diabetes: 2009-2017

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

73-LB: Continuous Glucose Monitoring Utilization and Associated Metrics in People with Diabetes on Insulin Therapy in the U.S

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Cost-effectiveness of TYRX absorbable antibacterial envelope for prevention of cardiovascular implantable electronic device infection

Journal of medical economics, 2018-03, Vol.21 (3), p.294-300

2018

Volltextzugriff (PDF)

The Association Between Adherence to Insulin Therapy and Health Care Costs for Adults with Type 2 Diabetes: Evidence from a U.S. Retrospective Claims Database

Journal of managed care & specialty pharmacy, 2020-09, Vol.26 (9), p.1081

2020

Volltextzugriff (PDF)

1027-P: Predicting Response to Bolus Insulin

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Predicting Response to Bolus Insulin Therapy in Patients With Type 2 Diabetes

Journal of diabetes science and technology, 2023-11, Vol.17 (6), p.1573-1579

2023

Volltextzugriff (PDF)

Economic impact of cardiac implantable electronic device infections: cost analysis at one year in a large U.S. health insurer

Journal of medical economics, 2020-07, Vol.23 (7), p.698-705

2020

Volltextzugriff (PDF)

Characterizing Diabetes Empowerment and Motivation for Changing Health Behaviors Among People with Type 2 Diabetes: A Cross-Sectional Survey

Diabetes therapy, 2023-05, Vol.14 (5), p.869-882

2023

Volltextzugriff (PDF)

Economic impact of converting from 10-mL insulin vials to 3-mL vials and pens in a hospital setting

American journal of health-system pharmacy, 2014-09, Vol.71 (17), p.1485-1489

2014

Volltextzugriff (PDF)

Healthcare costs and adherence associated with human regular U-500 versus high-dose U-100 insulin in patients with diabetes

Endocrine practice, 2014-07, Vol.20 (7), p.663-670

2014

Volltextzugriff (PDF)

Glycemic control and the first use of oral antidiabetic agents among patients with type 2 diabetes mellitus

Current medical research and opinion, 2013-12, Vol.29 (12), p.1587-1597

2013

Volltextzugriff (PDF)

The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study

Journal of medical economics, 2013-10, Vol.16 (10), p.1231-1237

2013

Volltextzugriff (PDF)

Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes

Clinical interventions in aging, 2015-01, Vol.10, p.991-1001

2015

Volltextzugriff (PDF)

Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysis

Journal of medical economics, 2013-04, Vol.16 (4), p.529-538

2013

Volltextzugriff (PDF)

Initiation of human regular U-500 insulin use is associated with improved glycemic control: a real-world US cohort study

BMJ open diabetes research & care, 2015-01, Vol.3 (1), p.e000074-e000074

2015

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(67)
Bücher
(1)

Sprache

Englisch
(68)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(39)
Science & Technology
(39)
Life Sciences & Biomedicine
(36)
Female
(22)
Male
(21)
Aged
(16)
Middle Aged
(14)
Insulin
(13)
Diabetes
(12)
United States
(12)
Biological And Medical Sciences
(10)
Adult
(9)
Medical Sciences
(9)
Retrospective Studies
(9)
Psychology
(8)
General & Internal Medicine
(7)
Medicine, General & Internal
(7)
Diabetes Mellitus, Type 2 - Drug Therapy
(6)
Endocrinology & Metabolism
(6)
Glucose Monitoring
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluating the relationship between clinical and demographic characteristics of insulin-using people with diabetes and their health outcomes: a cluster analysis application

The Health Effects of Restricting Prescription Medication Use Because of Cost

Insulin Dosing and Outcomes Among Commercially Insured Patients With Type 2 Diabetes in the United States

Adherence and Persistence to Insulin Therapy in People with Diabetes: Impact of Connected Insulin Pen Delivery Ecosystem

Treatment patterns, costs, and mortality among Medicare beneficiaries with CIED infection

Predictors of insulin pump initiation among people with type 2 diabetes from a US claims database using machine learning

50-LB: Using Cluster Analysis to Identify Attitudes towards Diabetes-Related Technology

Incidence, Treatment Intensity, and Incremental Annual Expenditures for Patients Experiencing a Cardiac Implantable Electronic Device Infection: Evidence From a Large US Payer Database 1-Year Post Implantation

Trends in U.S. Insulin Use and Glucose Monitoring for People with Diabetes: 2009-2018

75-LB: Use of Continuous Glucose Monitoring (CGM) and Its Association with Economic Outcomes in the Real-World Setting

1033-P: Trends in U.S. Insulin Use for People with Diabetes: 2009-2017

73-LB: Continuous Glucose Monitoring Utilization and Associated Metrics in People with Diabetes on Insulin Therapy in the U.S

Cost-effectiveness of TYRX absorbable antibacterial envelope for prevention of cardiovascular implantable electronic device infection

The Association Between Adherence to Insulin Therapy and Health Care Costs for Adults with Type 2 Diabetes: Evidence from a U.S. Retrospective Claims Database

1027-P: Predicting Response to Bolus Insulin

Predicting Response to Bolus Insulin Therapy in Patients With Type 2 Diabetes

Economic impact of cardiac implantable electronic device infections: cost analysis at one year in a large U.S. health insurer

Characterizing Diabetes Empowerment and Motivation for Changing Health Behaviors Among People with Type 2 Diabetes: A Cross-Sectional Survey

Economic impact of converting from 10-mL insulin vials to 3-mL vials and pens in a hospital setting

Healthcare costs and adherence associated with human regular U-500 versus high-dose U-100 insulin in patients with diabetes

Glycemic control and the first use of oral antidiabetic agents among patients with type 2 diabetes mellitus

The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study

Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes

Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysis

Initiation of human regular U-500 insulin use is associated with improved glycemic control: a real-world US cohort study

Suchergebnisse filtern